Literature DB >> 10680875

Delayed anterior ischemic optic neuropathy after neck dissection.

K Götte1, F Riedel, M C Knorz, K Hörmann.   

Abstract

There are only 2 published cases of anterior ischemic optic neuropathy (AION) occurring after neck dissection, to our knowledge. We report a case of bilateral AION following neck dissection, discuss the differential diagnoses, and compare the features of this case with those of previously described cases. There were none of the previously described risk factors for the development of AION after head and neck surgery (eg, hypotension, facial edema, or sudden massive hemorrhage) in this case, but there was prolonged diffuse postoperative bleeding. Also, the symptoms did not arise before the fifth postoperative day as they did in the other cases. Prolonged, mild postoperative bleeding is a risk factor for AION. Visual loss during the entire first postoperative week has to be regarded as a complication of surgery, requires the exclusion of several differential diagnoses, and must not be confounded with the patient's confusion or symptoms of withdrawal.

Entities:  

Mesh:

Year:  2000        PMID: 10680875     DOI: 10.1001/archotol.126.2.220

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  Perioperative visual loss in ocular and nonocular surgery.

Authors:  Kathleen T Berg; Andrew R Harrison; Michael S Lee
Journal:  Clin Ophthalmol       Date:  2010-06-24

2.  Bilateral anterior ischemic optic neuropathy after bilateral neck dissection.

Authors:  María J Suárez-Fernández; Antonio Clariana-Martín; Enrique Mencía-Gutiérrez; Esperanza Gutiérrez-Díaz; Teresa Gracia-García-Miguel
Journal:  Clin Ophthalmol       Date:  2010-03-04

3.  Influence of carbon dioxide insufflation of the neck on intraocular pressure during robot-assisted endoscopic thyroidectomy: a comparison with open thyroidectomy.

Authors:  Jie-Ae Kim; Jee-Soo Kim; Moon-Seok Chang; Yeon-Kyeong Yoo; Duk-Kyung Kim
Journal:  Surg Endosc       Date:  2012-10-17       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.